Damayanthi Yalamati

Biography

As a member of ARCI’s management team, Dr. Damayanthi Yalamati plays a key role in building the company’s profile and client base. Dr. Yalamati oversees the business development activities as well as ongoing contract research activities. Prior to ARCI she served as Manager of the Synthetic Biologics Business Unit at Oncothyreon (formerly Biomira Inc.), where she gained valuable experience in business development. Her contribution in the development of novel synthetic antigens and adjuvants resulted in many patents and strong intellectual property. Dr. Yalamati received her M.Phil. degree from the University of Hyderabad and Ph.D. from Osmania University, India. She moved to Edmonton, Canada to pursue her post-doctoral research at the University of Alberta. Her professional career has been in the field of cancer research, with a strong background in organic synthesis. She co-authored many US and Indian patents. Her work has been published in many peer reviewed international journals and presented at conferences. Her expertise in the synthetic antigens and adjuvants for the development of cancer vaccines, as well as small molecules for cancer therapies are valuable assets to ARCI.

Research Interest

Pharmaceutical Sciences